🤖 GLOBAL HEALTH OPTIMIZATION AGENT v3.0

🔬 Current Disease Focus:

Task Progress: 0%

👥 Active Problem Solvers

🌍 Experts collaborating globally

⚡ Current Task Assignment

🧬 Genetic Analysis

🔄 Matching experts to specific tasks

📊 Resource Allocation by Research Phase:

📚 Data Analysis

🧪 Experimental Design

🔬 Clinical Trials

💊 Treatment Development

Trial Search

Current Search Criteria:

Intervention: cisplatin and gemcitabine combination with Bevacizumab

Found 31 matching trials

A Safety and Efficacy Study of ZW25 (Zanidatamab) Plus Combination Chemotherapy in HER2-expressing Gastrointestinal Cancers, Including Gastroesophageal Adenocarcinoma, Biliary Tract Cancer, and Colorectal Cancer

PHASE2

This is a multicenter, global, Phase 2, open-label, 2-part, first-line stud...

Status

Completed

Location

USC/Norris Comprehensive Cancer Center

Start Date

2019-08-29

Trial ID

NCT03929666

Treatments Being Tested

ZW25 (Zanidatamab)Capecitabine Cisplatin Fluorouracil Leucovorin Oxaliplatin Bevacizumab Gemcitabine

Cisplatin and Gemcitabine With or Without Bevacizumab in EGFR Wild-type Non-Small Cell Lung Cancer

PHASE2

Advanced non-small-cell lung cancer (NSCLC) patients without epidermal grow...

Status

Unknown

Location

Sichuan Cancer Hospital

Start Date

2013-02

Trial ID

NCT01623102

Treatments Being Tested

cisplatin and gemcitabine combination with Bevacizumab Gemcitabine combined with cisplatin chemotherapy

A Study of Bevacizumab in Combination With First- or Second-Line Therapy in Subjects With Treated Brain Metastases Due to Non-Squamous NSCLC (PASSPORT)

PHASE2

This was an open-label, multicenter, single-arm, Phase II trial of bevacizu...

Status

Completed

Location

Multiple Locations

Start Date

2006-03

Trial ID

NCT00312728

Treatments Being Tested

bevacizumab First-Line Chemotherapy Agents Second-Line Chemotherapy Agents

A Study of TRK-950 in Combinations With Anti-Cancer Treatment Regimens in Patients With Advanced Solid Tumors

PHASE1

The main purpose of this study is to establish the safety and the recommend...

Status

Active Not Recruiting

Location

HonorHealth Research Institute

Start Date

2019-04-26

Trial ID

NCT03872947

Treatments Being Tested

TRK-950 TRK-950 TRK-950 Irinotecan Leucovorin 5-FU Gemcitabine Cisplatin Carboplatin Ramucirumab Paclitaxel Nivolumab Pembrolizumab Imiquimod Cream Bevacizumab PLD

A Single-arm, Multicenter Clinical Study of Iparomlimab and Toripalimab in Combination With Bevacizumab and Chemotherapy as First-line Treatment for Advanced Biliary Tract Cancer

PHASE4

This is a single-arm, multicenter clinical study designed to evaluate the e...

Status

Not Yet Recruiting

Location

Multiple Locations

Start Date

2026-07-01

Trial ID

NCT07619235

Treatments Being Tested

Iparomlimab and Toripalimab Bevacizumab Gemcitabine (1000 mg/m2)Cisplatin

Study of CGC-11047 When Used in Individual Combinations With 1) Gemcitabine or 2) Docetaxel or 3) Bevacizumab or 4) Erlotinib or 5) Cisplatin or 6) 5-Flurouracil or 7) Sunitinib in Patients With Advanced Solid Tumors or Lymphoma

PHASE1

This study will aims to determine the maximum tolerated dose of CGC-11047 w...

Status

Completed

Location

Rocky Mountain Cancer Centre

Start Date

2006-05

Trial ID

NCT00705874

Treatments Being Tested

CGC-11047 and gemcitabine CGC-11047 and docetaxel CGC-11047 and bevacizumab CGC-11047 and erlotinib CGC-11047 and cisplatin CGC-11047 and 5-flurouracil / leucovorin CGC-11047 and sunitinib

A Study to Learn About the Study Medicine PF-07985045 When Given Alone or With Other Anti-cancer Therapies in People With Advanced Solid Tumors That Have a Change in a Gene.

PHASE1

The purpose of this study is to learn about the safety and effects of the s...

Status

Terminated

Location

Highlands Oncology Group

Start Date

2024-12-10

Trial ID

NCT06704724

Treatments Being Tested

PF-07985045 Gemcitabine Nab-paclitaxel Cetuximab Fluorouracil Oxaliplatin Leucovorin Bevacizumab Pembrolizumab Sasanlimab pemetrexed Cisplatin Paclitaxel Carboplatin PF-07284892

A Study of Avastin (Bevacizumab) in Combination With Gemcitabine With or Without Cisplatin in First-Line Treatment of Elderly Patients With Non-Small Cell Lung Cancer

PHASE2

This 2 arm study will evaluate the efficacy and safety of Avastin + gemcita...

Status

Completed

Location

Multiple Locations

Start Date

2010-02

Trial ID

NCT01077713

Treatments Being Tested

bevacizumab [Avastin]cisplatin gemcitabine gemcitabine

Sintilimab Combination Therapy Plus IMRT in Nasopharyngeal Carcinoma

PHASE2

This is a prospective, single-center, single-arm, phase II clinical study. ...

Status

Unknown

Location

Multiple Locations

Start Date

2024-04-22

Trial ID

NCT06364826

Treatments Being Tested

Sintilimab, bevacizumab, gemcitabine IMRT

Cisplatin/Vinorelbine/Bevacizumab Followed by Docetaxel/Gemcitabine/Bevacizumab Versus the Cisplatin/Docetaxel/Bevacizumab Combination in Locally Advanced or Metastatic NSCLC

PHASE2

This trial will evaluate whether the sequential administration of Cisplatin...

Status

Completed

Location

University General Hospital of Alexandroupolis, Dep of Medical Oncology

Start Date

2008-01

Trial ID

NCT00620971

Treatments Being Tested

Vinorelbine Cisplatin Bevacizumab Docetaxel Gemcitabine Bevacizumab Docetaxel Cisplatin Bevacizumab

Previous Next